Inhibition of Cdc42-Interacting Protein 4 (CIP4) Impairs Osteosarcoma Tumor Progression

E-ISSN： 1873-5576|13|1|48-56

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.1, 2013-01, pp. : 48-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers

Current Medicinal Chemistry, Vol. 24, Iss. 32, 2017-10 ,pp. : 3485-3507

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of tumor progression by naturally occurring terpenoids

By Kuttan Girija Pratheeshkumar Poyil Manu Kanjoormana Aryan Kuttan Ramadasan

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 49, Iss. 10, 2011-10 ,pp. : 995-1007

Informa Healthcare

Access to resources Recommend Favorite

Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1574-1589

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cdc42 in cancer

By Arias-Romero Luis E Chernoff Jonathan

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1263-1273

Informa Healthcare

Access to resources Recommend Favorite

Cdc42 and the fundamental control of polarity

Reproductive BioMedicine Online, Vol. 8, Iss. 6, 2004-06 ,pp. : 725-725

Reproductive Healthcare Ltd

Access to resources Recommend Favorite